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The relative newness of ‘impact’ as a criterion for research assessment has meant that there is
yet to be an empirical study examining the process of its evaluation. This article is part of a
broader study which is exploring the panel-based peer and end-user review process for societal
impact evaluation using the UK’s national research assessment exercise, the Research Excellence
Framework (REF) 2014, as a case study. In particular, this article explores the different percep-
tions REF2014 evaluators had regarding societal impact, preceding their evaluation of this
measure as part of REF2014. Data are drawn from 62 interviews with evaluators from the
health-related Panel A and its subpanels, prior to the REF2014 exercise taking place. We show
how going into the REF exercise, evaluators from Panel A had different perceptions about how to
characterize impact and how to define impact realization in terms of research outcomes and the
research process. We conclude by discussing the implications of our findings for future impact
evaluation frameworks, as well as postulating a series of hypotheses about the ways in which
evaluators’ different perceptions going into an impact assessment could potentially influence the
evaluation of impact submissions. Using REF2014 as a case study, these hypotheses will be
tested in interviews with REF2014 evaluators post-assessment.
Keywords: societal impact; Research Excellence Framework; qualitative research; research
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1. Introduction
In 2014, the UK Research Excellence Framework (REF)
was the first mandatory national research assessment
body, which is linked to funding allocation, to dedicate a
formal proportion (20%) of its overall evaluation criteria
to considerations of societal impact. Societal impact of
research was assessed for REF ex post (after the event)
and was defined as ‘. . . an effect on, change or benefit to
the economy, society, culture, public policy or services,
health, the environment or quality of life, beyond
academia’ (Research Excellence Framework 2011: 26).
The REF2014 exercise for societal impact proceeded via
panel-based peer and end-user review assessment. During
such processes, a group of evaluators jointly deliberate and
judge the merit of whatever is being assessed, with a final
chair making the decision based on the common judgment
of all reviewers (Olbrecht and Bornmann 2010). The peer
review system is extensively used in academic research, and
as such it has been widely studied, with numerous scholars
pointing to both potential and observed risks. For
example, the individual peer review process, which occurs
during publishing, has been the focus of a breadth of
studies, with many scholars pointing to issues of bias
(Sandstorm 2009; Bornmann and Mungra 2011; Lee
et al. 2013). A number of studies have also examined the
process of panel-based peer review (Langfeldt 2006), with
an increasing body of literature exploring this process
during grant application decision-making (Bornmann
2011). In particular, some of this work has centred on
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the analysis of the social conditions that lead panelists to
view their judgments as fair, and to believe they are able to
identify the best and less good proposals (Lamont and
Huutoniemi 2011). In essence, scholars studying panel-
based peer review are interested in the decision-making
process—how decisions are reached and how group
dynamics influence the common judgment that is made
(Klein and Olbrecht 2011). Work has also focused on
exploring the advantages and disadvantages of such assess-
ment approaches (Klein and Olbrecht 2011). Advantages
have been noted as: evaluators being able to motivate each
other; being able to jointly re-evaluate their arguments; to
weigh up the arguments against one another; and to make
distinctions between important and less important argu-
ments (Olbrecht and Bornmann 2010; van Arensbergen
et al. 2014). On the other hand, group interaction has
been argued to result in poorer decision-making, because
shared responsibility creates a situation in which everyone
withdraws and no one really endeavours (Levi 2007; van
Arensbergen et al. 2014). Moreover, it has been suggested
that some of the alleged effects of individual peer review,
such as cronyism, self-interest, and cognitive particularism,
may influence the way panels are set up (Lamont and
Huutoniemi 2011).
The newness of societal impact as a criterion of assess-
ment means that little is known about the process of peer
review for such a measure. Indeed, the newness of the
impact criterion suggests a need to understand more
clearly how evaluative decisions are made about this
measure during the peer review process. This is particularly
true given the current contention about how societal
impact should be defined, evidenced, demonstrated, and
measured (Buxton and Hanney 2008; Mostert et al. 2010;
Spaapen and van Drooge 2011; de Jong et al. 2011;
Bornmann 2013; Bornmann and Marx 2014).
As the first mandatory, formal, ex post, peer and end-
user review assessment of societal impact linked to funding
allocation, REF2014 provides a good model for analysis of
societal impact evaluation, and indeed a world first case
study in which to explore societal impact in the context of
the process of evaluation. In light of this, this article is part
of a broader study which is exploring societal impact
evaluation specifically for research submitted for assess-
ment to the REF2014 health-related fields. This larger
study draws on interviews with evaluators both prior to,
and following, their assessment of impact. In the context of
this larger study, this particular article draws on 62 inter-
views conducted with REF2014 evaluators prior to them
engaging in the review process, and prior to their assess-
ment of societal impact for the REF2014, in order to
explore their perceptions about impact. At this time, inter-
viewees were aware of the significance of their upcoming
role as an impact evaluator for REF2014, and had access
to the REF2014 guidelines for evaluating impact, but had
not yet embarked on the process of assessment. This article
therefore describes the baseline different opinions of
evaluators about how they characterized impact in terms
of assessment prior to the REF exercise taking place. (In a
sister paper also reporting on the pre-evaluation inter-
views, we report evaluators’ baseline opinions about how
they valued societal impact with respect to scientific impact
(Derrick and Samuel 2015)). These pre-evaluation inter-
views therefore provide information about any different
characterizations about impact that would be brought
into the evaluation discussions, and inevitably contribute
to the development of the committee culture (Olbrecht
et al. 2007), thereby potentially influencing the evaluation
of impact submissions. In a following paper, we will
explore how these different perceptions unfold and influ-
ence the impact assessment peer and end-user review
process.
Below, we provide a brief literature review of societal
impact evaluation research, as well as describe the
REF2014 guidelines for health-related fields (Panel A) as
they relate to societal impact. We then present our
methods and discuss our findings. Finally, we consider
our findings and hypothesize about their potential influ-
ence on the peer review process when evaluators consider
impact as a measure during the REF2014. This will be
tested post-assessment, during the second stage of inter-
views with the evaluators, the results of which are not dis-
cussed in this article.
2. Literature review
2.1 Societal impact evaluation
There is an increasing expectation for research institutions
and funding bodies to demonstrate how the research they
fund offers demonstrable benefits to society. Many UK
research funding bodies have already introduced
measures to assess ex ante (before the event) societal
impact, most commonly recognized as the ‘pathways to
impact’ statement that appears as a constituent on many
of the UK grant application forms (Research Councils
UK). The Higher Education Funding Council for
England’s (HEFCE’s; which conducts the REF on behalf
of all four UK funding councils) decision to formally in-
corporate ex post societal impact as a criterion of research
assessment represents a further response to this expect-
ation, and has sparked great interest in this area.
Scholars have been informally developing and
appropriating a variety of tools for the assessment of the
societal impact of research, many of which informed the
development of REF2014’s impact evaluation guidelines.
These tools vary in their characteristics and criterion of
assessment, and, as such, contention about the definition
of societal impact, its characteristics, and how this reflects
different modes of evaluation still remains (Bozeman and
Boardman 2009; Holbrook and Frodeman 2011; Spaapen
and van Drooge 2011).
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The payback framework, developed initially for the
health sciences, was one of the initial research evaluation
tools that incorporated both academic outputs and societal
impact as a criterion for assessment. This framework,
which was developed during the 1990s (Buxton and
Hanney 1996), has been used to assess a number of
health science funding programs, including those in the
UK (Wooding et al. 2005), as well as internationally
(Bernstein et al. 2006; Kwan et al. 2007; Oortwijn et al.
2008; Scott et al. 2011; Donovan et al. 2014). It uses an
outcome-based retrospective, narrative, case study
approach to assess a series of five outcome categories of
individual paybacks from research. These include: know-
ledge production; research targeting, capacity building,
and absorption; informing policy and development
(which is interpreted very broadly and does not just refer
to national policies); health benefits; and broader
economic benefits (Hanney et al. 2004; Donovan and
Hanney 2011). The framework encompasses a somewhat
laborious and intensive process, and uses a multitude of
methods to collect and triangulate data, including inter-
views, questionnaires, bibliographic analyses, and
document analyses (Hanney et al. 2007; Kalucy et al.
2009). Scholars have also noted that it can be difficult to
‘capture’ impact (Martin 2011, 2012; Scott et al. 2011);
that attribution concerns make it difficult to determine
the exact contributions of research versus other factors,
in achieving the impact (Hanney 2005; Buxton and
Hanney 2008; Frank and Nason 2009; Kalucy et al.
2009; Buxton 2011; Scott et al. 2011); that there is a long
time lag between research application and societal impact
(Hanney 2005; Frank and Nason 2009; Kalucy et al. 2009;
Buxton 2011; Scott et al. 2011), which, as Frank notes can
take anywhere from 2 to 30 years from basic discovery to
effective therapy (Frank and Nason 2009); and that there
are a variety of different conceptualizations of impact
(Bornmann 2013). However, the framework’s multidimen-
sional categorization of benefits has been emphasized
(Hanney 2005), as well as its ability to help focus
analysis, organize the assessment of impact on non-
academic audiences, and provide consistency for present-
ing case studies (Hanney 2005; Klautzer et al. 2011). The
narrative, case study approach to societal impact evalu-
ation is therefore now considered best practice (Donovan
and Hanney 2011) and has been adopted in a number of
other similar outcome-based impact evaluation models
(Bornmann 2013).
Indeed, the narrative case study approach was a key
component to the evaluation of impact in Australia’s
national assessment exercise, the Research Quality
Framework (RQF). Whilst the RQF was never imple-
mented due to a change in government, the assessment
model was fully developed. This was by no means a
smooth process—the definition of impact, and how it
would be evaluated, was an incredibly contested issue
(Donovan 2008). Though, finally, a five-point impact
rating scale was developed geared towards end-user inter-
action in order to emphasize the need for activities and
mechanisms likely to enhance the chance of research
being utilized. Towards the lower end of the scale,
impact was characterized by an engagement with end-
users; and at the higher end of the scale, impact was
more outcome-based and characterized by the adoption
of research for society’s benefit (Donovan 2008). This
scale compliments the payback framework, which
recognized such end-user interactions in terms of ‘inter-
faces’, though stopped short of formally assessing them
as ‘impact’ (Hanney 2005).
Alongside the development of the above models for
societal impact evaluation, Spaapen and van Drooge
proposed the Social Impact Assessment Methods for
research and funding instruments through the study of
Productive Interactions (SIAMPI) (Spaapen and van
Drooge 2011). Similar to other methods of evaluating
impact (Scoble et al. 2010), the SIAMPI model recognizes
the fact that scientific research is not the sole contributor
to societal impact, with interactions between researchers
and stakeholders being important prerequisites (Molas-
Gallart and Tang 2011; Spaapen and van Drooge 2011).
In contrast, however, rather than assessing impact
outcomes, the central theme of SIAMPI is to explore the
process of impact, by capturing ‘productive interactions’
between researchers and stakeholders, and assessing their
value (Spaapen and van Drooge 2011). Spaapen and van
Drooge specifically define productive interactions as ‘ex-
changes between researchers and stakeholders in which
knowledge is produced and valued that is both scientifically
robust and socially relevant. . . The interaction is productive
when it leads to efforts by stakeholders to somehow use or
apply research results. . . Social impacts . . . are [then] be-
havioural changes that happen because of this knowledge’
(Molas-Gallart and Tang 2011; Spaapen and van Drooge
2011).
Spaapen and van Drooge argue that focusing on ‘pro-
ductive interactions’ help circumnavigate the time lag and
attribution issues commonly associated with outcome-based
modes of impact evaluation (Molas-Gallart and Tang 2011;
Spaapen and van Drooge 2011; de Jong et al. 2014). They
emphasize that assessing the process of impact allows an
evaluation which is ‘closer to the actual process that the re-
searcher is able to influence, that is closer to the actual
practice of the researcher doing research and interacting
with stakeholders’ (Spaapen and van Drooge 2011; 216),
and that by using productive interactions as an indicator
helps anticipate societal impact that may not yet have
occurred at the time of evaluation (de Jong et al. 2014).
2.2 Research Excellence Framework 2014
Based on a report by RAND Europe (Grant et al. 2009),
which recommended the RQF case study approach as the
most suitable assessment tool, REF2014 evaluated societal
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impact via narrative case studies. The structure of these case
studies, which were four pages in length, was tightly
controlled by the impact template supplied by HEFCE.
Within these templates, institutions had to nominate
pieces of underpinning research conducted at their institu-
tions—for example, reports in the grey literature, or
academic journal articles—and explain how this research
had had an ‘impact’ on society. The underpinning
research had to have been considered to have reached a
threshold of no less than ‘two stars’ in research quality.
That is, research that has a ‘quality that is recognised inter-
nationally in terms of originality, significance and rigour’
(Research Excellence Framework 2012a: 46). This
underpinning research must have been produced during
the time frame 1 January 1993–31 December 2013;
however, the described impact must have occurred
between 1 January 2008 and 31 July 2013.
The case studies were assessed by various panels. There
were four overarching Main Panels (Main Panel A–D)
which were loosely divided into fields of research, and
further divided into a number of subpanels responsible
for evaluating submissions from more specific fields of
research, or units of assessment. The responsibility of
each Main Panel was to provide overarching advice and
guidance to subpanels. Main Panels included, among
others, the Chair and Deputy Chair of each of the
subpanels and a number of international and UK-based
evaluators, as well as evaluators who were assigned by
HEFCE as academic experts (AE), or research users
(stakeholder) (UE) evaluators. The UEs were evaluators
predominantly from outside the academic sector and who
represented the private, public, or charitable sectors that
either use university-generated research, or commission or
collaborate with university-based researchers. However,
evaluators could be AEs, and also have a significant level
of experience working outside of academia.
Recognizing the newness of the criteria and its assess-
ment, it was key that the REF2014 guidelines defined
impact broadly. For health-related Panel A, impact could
be ‘achieved from within a wide variety of research contexts
and resulting from a wide diversity of approaches’, and there
was ‘no pre-formed view of the ideal context or approach’
towards impact (Research Excellence Framework 2012b:
33). Moreover, different types of ‘impact’ were recognized,
which could be viewed legitimately, and with equal
weighting for the REF2014 assessment of the case studies.
These included contributions to: health and welfare; society,
culture, and creativity; economy and/or commerce; public
policy and services; production; environment and practi-
tioners and services; and international development
(Research Excellence Framework 2012b). Indeed, the
REF2014 guidelines acknowledged that ‘impacts can be
manifested in a wide variety of ways including, but not
limited to: the many types of beneficiary (individuals, organ-
isations, communities, regions and other entities); impacts on
products, processes, behaviours, policies, practices; and
avoidance of harm or the waste of resources’ (p. 27). These
spanned, for example, those impacts related to interactions
with stakeholders and the public, such as evidence of influ-
ence on health policy and/or advisory committees, and
increased public awareness, understanding, and engage-
ment; through to changes in policy, document changes to
working guidelines, or the creation of spin out companies;
and also those more ‘final’ outcomes, such as improvements
in well-being, patient outcomes, employment figures, and
the development of new products. Furthermore, the
impact template stipulated the importance of research insti-
tutions’ approaches ‘to interacting with nonacademic users,
beneficiaries or audiences and to achieving impacts from its
research’ (p. 33), though such interactions were not assessed
formally as ‘impact’, and aspects of productive interactions,
such as public engagement, were explicitly stated not to be
used as evidence of impact in the REF evaluation guide-
lines. Rather, the REF2014 guidelines stipulated that
impact should be assessed against two outcome-based
criteria: significance and reach. Significance was defined as
the ‘intensity of the influence or effect’; whereas reach was
described as ‘the spread or breadth of influence or effect on
relevant constituencies’ (Research Excellence Framework
2012b). The assessment of impact was to be awarded
either one of five star profiles, where the lowest rating
(0—Unclassified) was where ‘. . . the impact has little to no
reach or significance, or was ineligible, or not underpinned by
excellent research produced by the significant unit’, and the
highest (four stars) was where the impact ‘. . . is outstanding
in terms of its reach or significance’ (Research Excellence
Framework 2011: 44).
The broadly conceived notion of societal impact assess-
ment developed by the REF orchestrators aimed to allow
the exercise to be refined over time, a factor openly
acknowledged by HEFCE. Even so, the move to incorp-
orate a societal impact assessment into the REF2014 has
been criticized on the basis that there are still too many
issues related to the nature of ‘societal impact’ and how it
will be evaluated, which still need ironing out. Scholars
have argued that societal impact is often indirect, partial,
opaque, and long-term leading to issues of attribution and
time lag (Martin 2011; Penfield et al. 2014); and that there
are still major conceptual problems regarding how impact
should be defined and assessed (Frank and Nason 2009;
Brewer 2011; Martin 2011; Bornmann 2013). Moreover, as
Brewer noted, impact ‘varies over time and can change,
positively or negatively, at the one-point snapshot whenever
it is measured’ (Brewer 2011:256).
3. Methods
3.1 Recruitment
HEFCE was informed and supportive of the research
project as long as it did not interfere or breach the confi-
dentiality agreement of the REF2014 evaluators and the
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evaluation process. Interview questions were provided to
HEFCE for review prior to the interviews taking place.
This coordination meant that all interviewees felt comfort-
able and adequately informed about the aims and object-
ives of the research project.
Interview participants were sourced purposefully from
Main Panel A, which covers six subpanels: (1) Clinical
Medicine; (2) Public Health, Health Services, and
Primary Care; (3) Allied Health Professions, Dentistry,
Nursing, and Pharmacy; (4) Psychology, Psychiatry, and
Neuroscience; (5) Biological Sciences; and (6) Agriculture,
Veterinary, and Food Sciences. The number of evaluators
assigned to each subpanel under Main Panel A ranged
from 51 (Allied Health Professions, Dentistry, Nursing,
and Pharmacy) to 27 (Public Health, Health Services,
and Primary Care). The Main Panel A included 19 evalu-
ators. A number of evaluators (n=20) were also repre-
sented on more than one subpanel. Each subpanel was
composed of both AE and UE (see Table 1).
Within these panels, evaluators were responsible for
evaluating outputs only, impact only, or both outputs
and impact. This research did not take into account
whether evaluators were also responsible for the
‘Environment’ criterion of the REF2014. This informa-
tion, therefore, was not collected.
A total of 215 evaluators were identified and invited to
participate in the projects. Invitations were originally sent
via email, resulting in a total of 62 evaluators agreeing to
participate in the interviews (28.8% response rate; see
Table 1). All interviewees were provided with a participant
information sheet and informed and/or written consent
was obtained prior to commencement of the interviews.
Ethics approval was granted on 22 November 2013 from
the Brunel University Research Ethics Committee (2014/
4), prior to the interviews taking place.
3.2 Interviews
Interviews were conducted via the telephone, skype, or
face-to-face, and were recorded, and transcribed for
analysis. Interviews lasted between 1 and 2 h, were semi-
structured, and were conducted by Gemma Derrick during
January to March 2014. In line with the study’s aims and
objectives, all interviews were completed before the
REF2014 evaluation process started.
To ensure the interviewees’ views about the definition
and characterization of impact were not influenced by
the interview discussion, the interview was opened with a
broad question regarding the participant’s definition of
impact (‘In your own words, please tell me how you
would define research impact?’). Following on, the inter-
view schedule incorporated a number of themes each
comprising of one, main, overarching question, followed
by a series of ‘prompts’ for further investigation.
Importantly, the semi-structured nature of the schedule
allowed the interview to flow as a natural discussion,
rather than the interviewer introducing new concepts,
which could inadvertently prompt a response. In this
way, the interview was interviewee-led with participants
driving the discussion, and cues about the ordering and
structure of the interview were taken from the interviewee.
The prompts were thus used to keep the interviewee on
topic, while also serving as a method to explore emerging
themes in more depth, and maximizing the strength of the
qualitative approach adopted in this study. Interview
themes were based around common issues currently dis-
cussed in the academic literature about the evaluation of
research impact and peer review (previously described).
Interview questions also drew on the participants’
previous research and peer-review research evaluation ex-
perience, and the influence of research impact in these situ-
ations. Participants’ past experience with impact was also
Table 1. The number of interviews conducted with REF2014 Main Panel A and its six subpanels
Subpanel name No. of
subpanel
members
No. of AEs (%
of AE’s) on
subpanel




pants (% of par-
ticipants) from
subpanel*
Main panel 19 14 (73.7) 5 (26.3) 8 (42.1)
Subpanel 1—Clinical Medicine 39 32 (82.0) 7 (18.0) 10 (25.6)
Subpanel 2—Public Health, Health services, and Primary
care
27 23 (85.1) 4 (14.9) 13 (48.1)
Subpanel 3—Allied Health Professions, Dentistry, Nursing,
and Pharmacy
51 42 (82.3) 9 (17.7) 14 (27.5)
Subpanel 4—Psychology, Psychiatry, and Neuroscience 35 28 (80.0) 7 (20.0) 9 (25.7)
Subpanel 5—Biological Sciences 35 30 (85.7) 5 (14.3) 6 (17.1)
Subpanel 6—Agriculture, Veterinary, and Food Science 29 16 (55.1) 13 (4.9) 4 (13.8)
Total 235 185 (78.7) 50 (23.2) 62 (28.8)
Note: Note that two of the participants sat on two different subpanels.
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used as a prompt to explore their opinions about the im-
portance of evaluating research impact, and its inclusion as
a formal criterion in the REF2014.
In the interests of confidentiality, all participant infor-
mation was coded and entered into NVivo (qualitative
analysis software package) for analysis. The codes used
in the results below relate to the participant’s panel
(Main panel=P0; subpanel 1=P1 and so forth) and
their evaluation responsibilities (outputs and impact
(OutImp); impact only (Imp); or output only (Out)).
3.3 Analysis
Analysis of interview data used an inductive approach to
grounded theory. Such approaches use an exploratory
style methodology, allowing concepts and ideas to
emerge from the data (Glaser and Strauss 1967;
Charmaz 2006). This method also empirically grounds
theorizing to data so that abstract conceptualizations can
be developed from a close analysis of the data.
As such, the analysis of data was based on two inter-
linked rounds: overview analysis and detailed analysis
(Strauss, 1987). Overview analysis consisted of memo-
making and broad coding. Extensive memo-making was
employed by the interviewer directly after each interview.
This allowed for the interviewer to reflect and note the
emergence of different themes for analysis, as well as to
draw parallels between interviewees as the interviews pro-
gressed. Broad coding by both the first and second author
was conducted by scanning the interview transcripts for
relevant ideas and themes. Discussion between the two
authors found no major disagreements in the emerging
themes. Codes were compared with these themes from
the memo-making, and three over-arching themes were
then developed. These were: value (the value, or types of
values, evaluators place on research impact); process (how
evaluators view the research and impact process); and
evaluation (evaluators’ views related to how impact will
be assessed). Themes were then used to inform detailed
coding of the full transcripts during a further, second
round of coding.
Detailed, line-by-line analysis of the interview tran-
scripts was employed using the NVivo software. As
outlined in grounded theory (Glaser and Strauss 1967;
Charmaz 2006), this coding was carried out using the
constant comparison method. This requires the compari-
son of codes to be constant, rigorous, and allow for de-
veloping and refining of conceptual categories and their
properties. In addition, duplicate coding by both the first
and second author was cross-checked to ensure reliability
of data.
4. Results
Below, we describe the different perceptions of societal
impact expressed during our 62 interviews with societal
impact evaluators. In particular, we describe how the
majority of evaluators perceived impact as an ‘outcome’
of research, though participants’ views varied with regards
to how much value they placed on different ‘research
outcomes’ when it came to impact assessment. Possible
implications of these perceptions in terms of assessment
are discussed, whilst at the same time acknowledging
that at the time of interviewing the evaluators had not
yet commenced the process of impact assessment, and
that their perceptions may change during this process.
We also describe how, rather than viewing impact as an
outcome, a small minority of interviewees viewed impact
as a process and placed value on research activities which
promoted research outcomes rather than the outcomes
themselves. We note the similarities between these views
and the SIAMPI model of assessment.
4.1 Impact as an outcome
The majority of interviewees defined societal impact as an
‘outcome’ (n=58): ‘[impact] is outcome focused’ (P4
Imp2). Outcome was mostly defined as a ‘change’ or a
‘difference’. For example, it could be a change to health,
such as to clinical practice (‘impact is demonstrating. . . that
the work that we funded actually is leading to, or has already
changed clinical practice’ (P1 OutImp4)), to public health
or the health service (‘what has changed public health’ (P1
OutImp2)), or to patient benefit (‘mak[ing] a difference to
patient care or outcomes for patients’ (P3 OutImp4)). More
broadly, others defined impact as ‘something that changes
people’s lives’ (P5 OutImp1) or something which has ‘made
a difference to the world’ (P5 OutImp5). Impact outcome
was also described in more economic terms as a ‘cre-
ation’—‘creating jobs, creating economic benefit to the
country’ (P1 OutImp6).
Whereas many participants consistently identified
impact as an outcome, beyond this, interviewees had dif-
ferent ideas about how they characterized this outcome,
and how these different outcomes could be weighted
against each other for the purpose of assessment. In par-
ticular, different opinions emerged regarding the point at
which interviewees perceived the research process to end,
and for ‘impact’ to commence, and therefore which
outcomes could be perceived as ‘impact’: ‘is there a point
which it ceases being a research outcome and being impact,
and where is that point?’ (P1 OutImp5). P1 OutImp5
illustrated the complexities of evaluating impact using
the exemplar of vaccine development. This interviewee
argued that each stage of vaccine development could be
viewed as a ‘different stage of impact’. Here, impact could
be initially realized when the infectious agent is determined
to be the cause of the disease. However, when developing a
vaccine, other impacts can all be additionally considered as
separate impacts, such as the first demonstration to be ef-
fective in clinical trials, and the ‘roll out’ of the vaccine
into the health system.
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There are different stages of impact . . . there [are] various
stages along the way where you start off with, we think the virus
is the cause of [the disease], so if we can do something about the
virus that has impact because it’s demonstrating causality, which
is something that was elusive. Then the next stage is can we
make the vaccine to this? [If] vaccine development [i]s
successful then the development of a successful vaccine is the
next stage of that impact. Then there’s the whole efficacy
argument, right? Okay, we’ve got a vaccine. How good is
it? . . .So, very rapidly the impact move[s] on from that point,
from individual clinical trials to actually being rolled out into . . .
programs, and having broad public health benefits
The issue then arises as to which stage or stages should be
evidenced as impact, and to what degree these should be
scored against each other. Further confounding this issue
was an alternative view of impact described by P1
OutImp5—one this interviewee commented would only
be held if ‘you were hardnosed about it’. This was
characterized solely by the realization of a health
outcome: ‘I guess if you were hardnosed about it, you
would say “well, actually it’s not impact until it’s had an
impact on the disease in people”. You may have rolled out
into the population, but until it actually starts to reduce the
incidence, it hasn’t had an impact’.
This ambiguity about how and when to define impact was
reflected in many of the views by evaluators. Many evalu-
ators were, as described above, ‘hardnosed’, perceiving
impact to only be achieved in the presence of a health,
economic, or similar ‘final’ outcome. For others, final
outcomes were graded most highly in terms of their
impact, but these evaluators also recognized the role of
other ‘secondary’ impacts, such as the ‘inclusion in guide-
lines’, ‘patenting’, and ‘clinical trials’; through to ‘drug de-
velopment’ or ‘policy development’. To a lesser extent, all
outcomes along the research process were considered along-
side each other and given equal merit—these were the ‘dif-
ferent stages of impact’ discussed by P1 OutImp5 above.
The ambiguity of impact definitions was, in itself, a
common theme expressed by all evaluators with very
little consensus found about impact across all interviewees,
including academic and user evaluators, including aca-
demics at different seniority levels, and including those
evaluators who considered their own research to have
had an impact.
4.1.1 Health or economic outcome as the measure of
impact. Many evaluators (n=19) perceived research as
having impact only after there had been a marked health,
economic, or other similarly ‘final’ outcome. These evalu-
ators recognized that there may be a number of stages
involved in the research process prior to achieving this
final outcome, but in terms of assessment, these stages
did not count as impact—rather, they were seen as the
means for ‘creating’ impact: ‘I think, they’re all part of
creating impacts. They themselves are not impact’
(P0 OutImp3). P2 OutImp3 illustrated this using the
example of research that had led to the development of
an assessment tool both inside and outside the UK. For
this interviewee, while this research had been ‘picked up’
and applied, the research was deemed too early a stage to
‘press all the buttons’ to be classified and assessed as
impact. Instead it could only hold a ‘promise’ of health
impact: It’s early days for exactly how successful they
will be in improving ultimate health outcome. . . and
hence it’s slightly early for the kind of pressing all of the
buttons for an impact case study. But. . . they have been
picked up. . . to different extents. . . they hold great
promise. Likewise, P0P1 OutImp1 talks about the ‘poten-
tial’ of impact: ‘so I can’t claim that I have impact achieve-
ment at this point in time, but it certainly has potential
impact’.
In terms of commercial impacts, other evaluators
perceived filing patents as a far cry from impact. In fact,
interviewee P1 OutImp4 highlighted how this exercise
made no significant contribution to translating research
into a ‘final’ outcome, and as such ‘was not rated highly’:
‘I would not rate highly in terms of impact somebody who
told me that as a result of the work they had done, there were
now three patents sitting somewhere. That hasn’t translated
in any way’. Likewise, for P3 Imp2, filing a patent or
creating a spin-off company was not itself an ‘impact’,
rather it is ‘what is done with them’ that creates value:
It’s not the filing of the patent which is important. It’s what you
do. Creating a spinoff company in and of itself, not important,
not really. What’s important is that [the] company does
something. There’s an application or a creation of value using
that spinoff company as a means for doing that
A similar sentiment was observed for the inclusion of
research into guidelines or policy documents, which were
considered as not always bringing an additional ‘outcome’
in terms of health, economics, or other ‘final’ outcomes (‘a
lot of policy doesn’t have any impact at all, as far as I can
tell’ (P3 Imp2). Indeed, these practices were viewed as an
‘intermediate measure’ that ultimately was not very
‘inspiring’ and did not have ‘a terribly profound effect’
(P2 OutImp8). Being ‘mentioned in a parliamentary
report’ or ‘sitting on a select committee’ was likewise
viewed with scepticism. These activities were characterized
as being ‘ephemeral’, by not having a long-lasting effect on
society or on any change in terms of health or economics.
In fact, these activities were defined as more to do with the
esteem of the researchers themselves, rather than the actual
outcome of the research:
I’ve got a little bit of an inherent scepticism about the impact
case study which says ‘we were mentioned by this parliamentary
report, there was a select committee or an all party committee
which ran a meeting about this’, because on the one hand those
were terribly flattering . . . but on the other hand I think they tend
to be pretty ephemeral (P2 OutImp8)
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This distinction between the research and the researcher
is interesting and is returned to in the final section of the
results during the discussion about impact as part of the
research process.
4.1.2 Impact as incremental stages. For some
evaluators (n=39), impact amounted to more than just
the final outcome, it was characterized by ‘identifying the
thresholds in the movement towards that final product, and
who contributes to those thresholds’ (P0 OutImp6). For
these evaluators there was a gradation of impacts: ‘I
guess there is no single ultimate impact, there’s a gradation’
(P1 OutImp4). However, in terms of assessing the impact,
evaluators differed with regards to the amount of weight to
place on these incremental stages.
For a small number of evaluators (n=6), outcomes
such as ‘policy change’ or ‘halting drug development’
were viewed as impact to be assessed on par with ‘final’
outcomes. For example, P2 OutImp9 talked about how
contributing research to guidelines is a form of impact: ‘I
work on a guideline steering group, I know that my research
gets quoted. I know that it gets picked up. The study that I’ve
worked on is regarded as one of the important studies . . . so I
believe that that has an impact’ (P2 OutImp9). Referring to
the development of a drug from basic research, P0
OutImp6 re-iterates the importance of recognizing early
outcomes as impact. For this interviewee, discovering
during the first stages of the research process that a
particular protein is implicated in a disease is impact just
as much as the final development of a drug. Early
outcomes are part of realizing the development of a drug
and therefore must be valued equally. Referring to the star
scale of the impact evaluation system used in the REF2014
assessment that requires evaluators to rate the ‘impact’
from zero to four stars, this interviewee emphasized that
as long as research had ‘moved to another stage’ it could
be considered four-star impact:
If . . . you discover a new protein . . . you can’t expect . . . to have
impact in terms of an entirely new drug or entirely new
diagnostic test if that protein is changed in a disease, because
that takes years and many people to do that. What I would
expect . . . is that protein, to move on to another stage . . . to turn
it into something that might be practical, and so to me that’s a
four-star impact just as much as producing a drug at the end of
the day..[..]..and we’re going to have to make sure that they’re
valued just as much as the final product (P0 OutImp6)
For other evaluators (n=33), outcomes achieved earlier
in the research process were also considered impact, and
therefore warranted inclusion in the REF2014 impact
assessment. However, their inclusion was characterized
by being ‘second-level’ impacts or ‘intermediates’ and
therefore not as worthy as the ‘final’ outcome:
[The] number of times that appears in NHS policy documents or
department of health policy documents . . . that’s impact of a
kind, but I think that’s a sort of second-level impact . . . frontline
is patient impact; the second line behind that would be having an
impact on policy and practice documents (P3 OutImp1)
Similar to the idea of ‘promise’ drawn out by evaluators
in the above section, these evaluators acknowledged that
these intermediate practices could only potentially lead to
‘final’ outcomes, and assessment needed to reflect this. As
P4 Imp1 stressed, intermediates only ‘might’ lead to such
final outcomes: ‘things like NICE guidance, textbook
references being made in key media, that might lead to a
health outcome’ (P4 Imp1).
Consequently, for these evaluators, the final outcome,
whether health, economic, or other, was still regarded as
‘the most important thing’—‘the biggie’. Again, referring to
the star scale of impact evaluation to be used in the
REF2014, P1 Imp1 highlighted the different types of
‘impact’ with reference to comparing the most important
four-star outcome of ‘avoiding deaths’ to two or three
star outcomes, such as ‘changing practice’:
The most important thing is how many deaths from cancer have
we avoided? . . . And then you can go down to saying, ‘well, have
we changed practice, have methods been developed?’ Or various
sorts of things that you come along the way we might call it one
and two and three stars. But really . . . the biggie we’re looking
for is reduction in mortality or increasing quality of life (P1
Imp1)
For the evaluators described above—evaluators who gave
weight to impact occurring at various stages of the research
process prior to the ‘final’ outcome—an important
implication emerges in terms of societal impact evaluation:
what might have earlier in the research process appeared to
‘have an impact’, may subsequently lead to a ‘negative’ or
‘wrong’ effect: ‘there is lots of research that has an impact in
the short-term and turns out to be wrong or misguided once
the time has passed’ (P0 OutImp2). For example, in cases
when a policy passed by a government turns out to be
detrimental: ‘because you could have an impact in terms of
changing government policy but. . . that change in government
policy actually has a detrimental effect because you got it
wrong’ (P6 OutImp2). One interviewee drew on the
example of the development of drugs, to exemplify this
point. This participant stressed how, at first, despite being
twice as expensive, a particular generation of drug appeared
more beneficial than others, and was therefore incorporated
into practice. A few years ‘down the line’, this generation of
drug was found to be without the originally claimed benefits
and would have consequently cost the health service twice
as much, with no parallel patient benefit:
If it [a new generation drug] is discovered to [have] a significant
outcome versus the cost to work, and then . . . if you measure the
impact at the end of the first round of publication, you say ‘it’s
great; these things are going to be twice as good’. And if you
measure them at the end of the second round of publication,
you’d say, the impact is terrible; it’s cost us over twice as much
money for the last 10 years (P3 OutImp3)
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This is unproblematic if impact is perceived as value
neutral or, in other words, if no judgment is made
during assessment about whether a specific impact harms
or benefits society. However, many evaluators did not
perceive impact as such. For them, impact was about
‘making a positive change’ or ‘improving’ society: ‘for
me. . . impact is when you do research, someone takes it up
in the real world and makes a positive change’ (P2
OutImp2); ‘impact for me is something is going to change,
something is going to improve’ (P4 Imp2). Measuring
impact therefore required the input of a value judgment:
‘there’s a value judgment involved in assessing positive
impact, isn’t there? It’s just to assess the impact generally
objectively seek some criteria and measure them. But
whether that resulted in better health outcomes or better
health behaviours or something, that’s another issue’ (P4
Imp1). Value judgments such as these raise questions
about defining ‘positive’ impact and making assessments
about whether such undefined ‘positive’ outcomes should
be valued over and above other outcomes as ‘impact’.
Different implications emerged for those evaluators who
viewed ‘final’ outcomes as the ‘biggie’ in terms of impact.
First, in terms of basic and applied research, researchers
earlier in the process would not be credited for delivering
any final outcome if in consecutive evaluations an outcome
from a specific piece of research can only be claimed and
attributed to the applicants initially involved in the
development of the research since, but not prior to, the
previous assessment. In P2 Imp2’s example of the breast-
screening programme described above, if the health
intervention was claimed initially as an impact outcome,
only those researchers conducting research after the
intervention could realistically claim any ‘final’ health
outcome. Researchers therefore working at different
stages of the research process will be scored differentially
and potentially lower, for this impact. Second, an issue of
time lag exists. This issue has been extensively discussed in
the literature (Spaapen and van Drooge 2011; Penfield
et al. 2014) and relates to the length of time it often
takes for health outcomes to be realized. For example,
P2 Imp2 noted that while there had been an extension of
a breast-screening programme, and this is no doubt being
‘felt’ because the programme had changed significantly; it
will be ‘ages’ until data emerge to tell whether this
particular change in the programme has achieved the
desired health outcome, and therefore impact:
Sometimes it takes ages to demonstrate the outcome. A good
example might be the extension of the breast-screening program
down to 57 and up to 73. The recent work that’s being done will
demonstrate what impact that has, what outcome that has on
women, but not for ages; but it’s absolutely certain that even now
there’s impact being felt because the program has changed
significantly (P2 Imp2)
In these instances, by the time the health outcome of a
particular piece of research had been realized, it would
be too late to claim impact in terms of the ‘final’
outcome. Evaluators viewing impact solely in terms of
‘final’ outcomes may therefore exclude recognition of
impact on the grounds that ‘it’s the old, “it’s too early to
say” thing’ (P4 Imp1); or alternatively it could promote a
downgrading of those case studies by other evaluators who
viewed the final outcome as the ‘biggie’. There was,
however, scope in the existing REF2014 impact evaluation
guidelines for exceptional cases of research to be extended
further back than 20 years (the current threshold for the
underpinning research), and also the possibility that
subsequent impacts could be submitted for future
evaluations. However, this raises questions of whether
the submission of multiple, smaller impacts rather than
the more long-term consideration of the entire ‘impact
journey’, could significantly disadvantage applicants in
terms of the overall impact assessment score obtained.
Overall, the views expressed above favour a
characterization of impact as an outcome over a process
involving a number of individual impact events. This
aligns with the context of the REF2014 guidelines for
impact evaluation, and is also similar to the way impact
is represented in the payback framework for research
evaluation. We cannot draw too many conclusions about
the implications of holding different views about the
characterizations of impact discussed above because
these views reflect evaluators’ beliefs prior to, and not
during, their assessment of societal impact, their
implications can only relate to these pre-evaluation
views, and not to the review exercise of societal impact
itself, during which opinions are likely to change. They
are, however, worthy of a mention because, as part of a
larger study which is exploring the review process for
societal impact evaluation using REF2014 as a case
study, these implications can be revisited in greater detail
later, and compared with the findings from the interviews
with REF2014 evaluators following the review process. In
this way we can explore how any such implications may
have been addressed during the review exercise.
4.2 Valuing the process of impact
A number of interviewees (n=18) recognized that impact
was contingent on social processes. They perceived that the
possibility of impact being realized was more related to a
range of social factors, than adequately reflecting the
nature of the research, or the efforts of the researchers
themselves. This concept is built from the observation
that the societal impact of science is not value-free and
neutral and that science does not have an impact based
solely on its particular capabilities. Rather, scientific
research, its shaping and development, and its application
to society, is related to multilayered social factors (Brown
and Webster 2004). These social factors, which are
unrelated to the scientific nature of the research or
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researchers themselves, can represent a facilitator or a
barrier to impact being achieved.
Indeed, some interviewees were aware that outcomes of
research were dependent on a whole range of
‘uncontrollable’, ‘outside factors’ (or ‘forces’) that needed
to be overcome: ‘there are forces out there that try to inhibit
development as well as encourage it’ (P0 OutImp6) (n=40).
Some ‘forces’ were viewed as a barrier to impact, whilst
others were seen as ‘aiding’ it. These forces, which have
been described in relation to evidence-informed health
policymaking (Haynes et al. 2011) include facilitating
factors such as serendipity, along with more impeding
factors, such as whether the research is ‘fashionable’:
‘often its not to do with the quality of the research. It’s a
whole lot of other things about workplace cultures and what
is the kind of fashionable thing of the time’ (P3 OutImp5);
ready to be accepted: ‘it take s a long time for things like
that to be accepted’ (P1 OutImp2)); desired: ‘you could do
excellent research that wasn’t impacted because stakeholder
groups didn’t want to take it up’ (P4 Imp1); or financially
viable: ‘say a pharmaceutical company does buy a
product . . . and then they decide not to develop it. That
won’t be because of scientific reasons . . . but maybe just
for financial reasons’ (P0 OutImp6).
A number of evaluators also acknowledged that in order
to overcome many of the ‘barriers’, and ‘push research
towards impact’, researchers needed to engage with
stakeholders—in fact generating an outcome was viewed
by some evaluators as dependent on overcoming barriers
to impact via engaging with stakeholders (n=36). These
engagements were discussed in terms of ‘building
relationships’. Rather than the research itself, these
relationships—be them with industry, policy makers,
and/or patient groups—were perceived to be a necessary
link between research and impact:
Unfortunately in the real world, things often turn on whether or
not you’ve got someone’s ear in high places—whether that would
be the trust chief executive or the public health agency chief
executive or the permanent secretary—a lot of impact still is
built around personal relationships (P2 OutImp4)
Whilst many evaluators recognized the importance of
social processes in determining outcomes, and the necessity
to ‘push’ research forward, this was only sometimes taken
into account when considering how to value impact
realization. P4 OutImp6 was one such interviewee who
considered this. This participant highlighted the
importance of recognizing a policy change as ‘impact’,
even in instances when the change has ‘not been taken
notice of’. For this evaluator, being noticed is a separate
social matter, and therefore the outcome still deserves
recognition as an impact. With a similar sentiment, P6
OutImp2 was concerned that if a case study presented a
specific drug which never made it to market, other
evaluators would think they were having the ‘wool pulled
over their eyes’ in terms of assessing impact. However, this
may ‘not be your fault’, according to this interviewee,
because it might have more to do with commercial
decisions, than scientific issues:
Let’s say . . . you are now making a new drug . . . [the]
company’s bought it, but the company decides to keep it on the
shelf because they don’t want to market it right now. How do you
measure that? They [other evaluators] will just say you are just
pulling the wool over my eyes; it didn’t get to the market . . .
[but] it’s not your fault—there is nothing wrong with the
discovery, and there is nothing wrong with the pathway you’ve
taken. It’s just that a commercial decision has been taken by the
company (P6 OutImp2)
For this interviewee, then, such external factors need to be
considered when evaluating impact.
For a small proportion of interviewees (n=4), rather
than any research outcome, it was the interactions
researchers formed with stakeholders during the impact
journey to promote their research, which were weighted
heavily when evaluating impact. Impact was therefore
best shown by the efforts of researchers trying to ‘get
their research out there’, and it was these interactions
which these interviewees believed should be assessed as
impact: ‘the question we should be asking is whether
enough effort has gone into that in the past and levering
research into its next stage’ (P0 OutImp6). This interviewee
continued: ‘the most important part of the impact
assessment is . . . the journey really, from the discovery to
that next end stage and . . . I’m trying to add value to that
journey and look for how the university or researcher use
that opportunity to get to that next stage’ (P0 OutImp6).
For these evaluators, impact was perceived not so much
as a ‘noun’, but rather as a ‘verb’: ‘if you think of impact as
a verb rather than a noun, I think it’s a lot easier to analyse’
(P0 OutImp4). Impact was something that a researcher
could do to push research forward, rather than the end-
point or sole outcome of a research process:
Impact is the relationships you build. It is the dialog that you
have that makes you ask research questions that are subtly
different from the ones you would have asked if you hadn’t linked
with whether it’s policymakers, whether it’s citizens, whether it’s
industry at the beginning. So impact is not something that you
have right at the end. Impact is a relationship and that attitude of
mind that you have throughout the research process (P0
OutImp4)
By incorporating stakeholder interactions as a criterion of
impact assessment, these evaluators felt that the
researchers would be rewarded, as opposed to the
research. Activities such as, sitting on a committee,
which was characterized earlier as ‘terribly flattering’ but
‘ephemeral’ (P2 OutImp8), were therefore valued by such
evaluators. As mentioned above, no distinct differences
were found in the views expressed about impact expressed
by the academic evaluators and the user evaluators. Rather
than being based on the REF model of impact assessment,
such views about impact resonate with the SIAMPI model
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of evaluation, which argues the importance of evaluating
productive interactions between academics and
stakeholders as a criterion of assessment for societal
impact (Spaapen and van Drooge 2011).
5. Discussion and conclusion
This article reports on a series of 62 interviews with
REF2014 evaluators of impact prior to undertaking its
formal assessment. The findings highlight the range of
views evaluators had about how impact should be
characterized during assessment. We have shown how
the majority of evaluators viewed impact as an ‘outcome’,
and that many valued the ‘final biggies’ as the most
important aspect of impact. We have discussed some of
the potential implications of these opinions.
At the time of interview, participants were aware of the
importance of their forthcoming role as an impact
evaluator for REF2014, and had access to the REF2014
guidelines for evaluating impact, but had not yet embarked
on the process of assessment. These findings are therefore
important as they describe the baseline different opinions
of evaluators about how they characterized impact in
terms of assessment prior to REF2014 taking place. This
is useful as it provides policymakers embarking on other
future impact evaluation frameworks, both nationally and
internationally, with a rich description of the different
types of conceptualizations impact evaluators may bring
to formal assessment frameworks before embarking on
assessment, and therefore has implications for the peer
and end-user review process by which impact is assessed,
as well as how future guidelines for impact evaluation are
formulated. In particular, it reminds policymakers of the
importance of starting debate early about the definition of
impact, at the initial stages of evaluation framework
development, in order to tease out evaluators’ specific
issues and concerns. Such concerns have the potential to
influence how evaluators implement evaluation guidelines
(Benda and Engels 2011), as well as the culture of the
evaluation committee which has been shown to impact
on peer review outcomes (Kerr et al. 1996).
Further, whilst we have noted that we cannot draw
conclusions at this stage about how evaluators’ perceptions
will effect the impact assessment exercise due to the likely
shift in opinions during the process, as baseline opinions,
they do serve to highlight a number of hypotheses to now be
tested about the process of impact evaluation.
One key question, relates to whether evaluators change
opinions about impact characterization during the process,
and what the reasons are for any such change. This will shed
light on how the process has influenced evaluators’ views
and beliefs about impact and how the potential benefits or
drawbacks of this can be applied to any future evaluations
of impact. This will be explored in the next stage of research
that will include post-evaluation interviews. This will be
done by combining the results obtained from the pre-
evaluation interviews described above, with results
obtained by the second, post-evaluation interviews. The
unfolding of this question will also have an influence on
the further hypotheses to be tested, discussed below.
A second important question, relates to what extent
evaluators’ varying opinions about impact characterization
will influence their interpretation of the REF2014 impact
criteria of ‘significance’ and ‘reach’. The way in which
interviewees characterize impact will reflect their research
and experiences, and we hypothesize that therefore such
views will at least play some role in defining what
characteristics impact evaluators look for when using the
‘significance’ and ‘reach’ criteria. For example, we
hypothesize that interviewees varying conceptualizations
of an ‘impact outcome’ will be reflected in how the
‘significance’ and ‘reach’ criteria are applied to the case
studies—with different evaluators regarding the necessity
for certain ‘signposts’ or ‘indicators’ for case studies to
receive a high star rating. Similarly, we hypothesize that
those interviewees, whose views of impact aligned more
with the SIAMPI model of assessment, may score impact
case studies in favour of a process—that is, not only on the
basis of significance and reach, but also in consideration of
how such significance and reach was achieved. These
practices of looking for specific signposts within the data
that reflect evaluators’ own conceptualizations of impact
may also be applied to other conceptualizations of impact,
for instance, whether an impact needs to have a benefit, or
just have the potential for a benefit.
The third question would be to see the extent to which
evaluators’ viewpoints develop differently during peer
review panel deliberations. It is well established that peer
review is not a socially dis-embedded process in which
reviewers apply a set of objective criteria to assessment,
rather, it is widely influenced by group interactions and
social factors (Glaser and Laudel 2005; Bornmann 2008).
In addition, it is a process of social interaction, with some
scholars going as far as arguing that decisions are, in fact,
socially constructed (Glaser and Laudel 2005). van
Arensbergen has pointed to differences in, for example,
status and expertise of the panelists, which play important
roles in this type of interaction (van Arensbergen et al.
2014). And in their analysis of committee peer review,
Lamont and Huutoniemi have demonstrated that it is
customary rules followed by panelists which guide panel
deliberations, and that these rules are never formally
taught, but are learnt through professional socialization
(Lamont and Huutoniemi 2011). These authors argue that
social conditions brought about by such rules lead panelists
to build consensus with other evaluators, and to perceive
the process as fair (Lamont and Huutoniemi 2011).
Alongside these studies, Langfeldt has shown that
guidelines given to panels during grant peer review had
little effect on the criteria the evaluators emphasized as
key for assessment, rather panels based their decisions on
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factors not supposed to influence judgment (Langfeldt
2001). Other research has also shown how group
dynamics influence final judgments on peer review panels
(Klein and Olbrecht 2011). The question thus remains as to
how bringing people together from differing backgrounds
influences what type of consensus is reached about the value
of impact. This will be particularly interesting to see in
terms of the academic- and user-evaluators, despite, no
differences being found between their views expressed
prior to assessment commencement.
Finally, in the case of formally evaluating impact under
the REF2014, the newness of the impact criterion and the
continued debate about its definition, raises questions about
the actual practice of evaluating societal impact.
Specifically, with the range of views about impact discussed
in this article, including most evaluators viewing impact in
terms of the ‘final’ outcome, questions are raised about how
social interactions and evaluator roles will inform and
determine the decision-making process required to reach a
consensus of opinion. Indeed, by applying such
considerations, as well as considerations of how the panel
members interact, our final hypothesis is that the emerging
dominant definition of impact used to guide its evaluation
will reflect those most prominent opinions about impact
expressed by the evaluators prior to the evaluation process
and discussed here in this article. Indeed, Orbrecht and
Bornmann (2010: 302) have argued this very point in
terms of peer review assessment—that ‘if the reviewers
have different opinions, pressure for a consensus could result
in acceptance of the majority position without adequate
consideration of deviating opinions’ (Olbrecht and
Bornmann 2010). They have argued that such occurrences
are more likely in circumstances similar to REF2014, where
no formal guidelines for the judgment process exist; the
group works together as a panel over a long time; and
when the panel is under stress to evaluate a large number
of applications within a short period of time (Olbrecht and
Bornmann 2010). This will therefore be one of the key
themes of exploration in the next stage of this larger
research project, which will include re-interviewing
evaluators post-assessment. It is hoped that by exploring
and comparing the different views of evaluators both pre-
and post-evaluation, important insights into how societal
impact can be effectively evaluated by peer- and user-
based review in the future will be learnt.
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